Austral-Asian Journal of Cancer ISSN-0972-2556 is the first international cancer journal published from Asia and Australia. This journal is a multidisciplinary oncology journal covering all aspects of cancer treatment and research. The journal has 9 editorial offices. The journal is affiliated to and released by Regional Cancer Centre - Trivandrum - India, Leukaemia Foundation of Australia - Australia, Gunma University - Japan, Kuwait Cancer Control Centre - Kuwait. The main objective of this journal is dissemination of information on cancer research and treatment to the scientists and institutions mainly in the developing and underdeveloped countries at an affordable price.

Chief Editors

Dr. Thomas Koilparampil, MD
Radiation Oncologist & Consultant in Palliative Care
Regional Cancer Centre
Medical College P.O
Trivandrum-695011, Kerala, India
Tel: 91-471-2522343
Fax: 91-471-2447454
E-mail: rcctvm@md2.vsnl.net.in

Dr. Mohammad A. Al-Jarallah, FRCS
Senior Consultant Surgeon
Room No.4038, 2nd Floor, P.O. Box No.31988
Ministry of Health
Suleibikhat, 908010
Kuwait
Tel & Fax: 00 965 4863457
E-mail: aajcancer00@hotmail.com

Austral-Asian Journal of Cancer is the academic publication of Regional Cancer Centre, Trivandrum- India; Kuwait Cancer Control Centre- Kuwait; Leukaemia Foundation of Australia- Australia; Gunma University-Japan and University of Patras Medical School, Patras, Greece.

Editorial offices are functioning in India, Kuwait, Australia, Japan, Poland, Tanzania, Sweden, Iceland and America.

AJC Vol.7, No. 3, July 2008

EDITORIAL –

PROFILE

ARTICLE

1) Assessment of Prognostic Factors for Non-Small-Cell Lung Carcinoma Following Radiotherapy of Cerebral Metastases
Prof. AM dr hab. n. med. Maria Mazurkiewicz (Poland)

2) How is radio frequency Ablation going in treating Hepatocellular Carcinoma in China ?
Dr. Wenbing Sun (China)

3) Reconsideration of Radiation Therapy for Liver Carcinoma
Dr. Xia Tingyi (China)

4) The Overview of the PHC Therapeutics in China.
Dr. Gong Li. M.D, Dr. Shuai Jin M.D. (China)

5) Gefitinib (Iressa) in Non Small Cell Lung Cancer at Kuwait Cancer Control Centre experience, Kuwait, with focus on future use of EGFR- tyrosine kinase inhibitors.
Dr. Vinay Vyas (Kuwait)

6) Is this acute Lymphoblastic Leukaemia (All) or juvenile Rheumatoid Arthritis (JRA)
Dr. Chellam Kirubakaran (India)

7) A case of Breast cancer co-existing with B-cell Follicular Lymphoma
Dr. V.S.Suresh Atilli (India)

8) Isolated vesical metastasis from primary gastric adeno carcinoma
Dr. Ullas Batra (India)

9) REVIEW OF THYROID CANCER IN IRAN *********
Dr. B. Larijani, MD (Iran)

10) The effect of Shark Cartilage on the Modulation of Cytokine Responses in invasive Ductal Carcinoma of Breast Cancer Patients
Dr. Zuhair M. Hassan (Iran)

11) Cholangicarcinoma : Diagnosis and management
Dr. Lars E Schmidt (Denmark)

12) The pathology of placenta accreta, a modern epidemic.
Dr. T.Y.Khong (Australia)

13) Primary Biliary Cirrhosis In Brazil Clinical Laboratory Histological And Immunogenetic Features
Dr. Alberto Queiroz Farias (Brazil)

14) Spatial registration of functional NIRS data to the standard stereotactic brain coordinate system.
Dr. Ippeita Dan (Japan)

15) Dependence of Wedge Transmission Factors with Depth and Field Size for Therapeutic Photon Beams
Dr. M. Ravikumar (India)

16) Dendritic cell vaccination for cancer immunetherapy
Dr. Georg Sprinzl (Austria)

17) Methotrexate pharmacokinetics and survival in Osteosarcoma
Dr. Irene Aquerreta (Spain)

18) A case for inhibiting Head & Neck Cancer Progression by Isothiocyanates and Indoles from Cruciferous Vegetables in Central Asia and the Pacific Rim
Dr. Jay H. Fowke (USA)

19) Osteonecrosis of the Jaws Secondary to Biophosphonate Therapy - A Case Series
Dr. Parish P.Sedghizadeh (USA)

20) Pharmacogenomics of Cancer Chemotherapy
Dr. G.J.Peters (The Netherlands)

21) Fine Needle Aspiration Biopsy of Elastofibroma Dorsi Revisited
Dr. Henryk A Domanski (Sweden)

22) Molecular Diagnostics of Bone and Soft Tissue Tumours
Dr. J.V.M.G.Bovee (The Netherlands)

23). Breast Cancer Risk Assessment and Prevention: A Framework for Shared Decision Making Consultations
Dr. Elissa M. Ozanne (USA)

24) Comparison of the BACTE MGIT 960 System and Lowenstein-Jensen Medium for Detection and Recovery of Mycobacteria from Smear-Negative Specimens
Dr. Daniel Asrat (Ethiopia)

25) Patients with Inflammatory Disease and Cancer are at Risk of Developing Malignant Diseases and Life-threatening Degenerative Diseases, Respectively, Due to the Impact of Chronic Systemic Inflammation
Dr. James T.Wu (Taiwan)

26) Dendritic Cells as Prognostic Indicators or as Immunotherapeutic Tools to Treat Acute Myeloid Leukemia (AML) and High Grade Myelodysplasia (MDS)
Dr. Helga M.Schmetzer (Germany)

For enquiries and feedback contact us : irpcasia@md4.vsnl.net.in